Q32 Bio Inc.
USD12.64
+0.98 (+8.40%)
CEO
Jodie Pope Morrison
IPO Date
2018-03-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$12.54
Prev. Close
$11.66
Day Low
$11.51
Day High
$13.19
52W Low
$1.34
52W High
$13.19
Market Cap
$0.16B
Volume
0.78M
| 625,000 |
| $8.00 |
| 1 Jun 2026 | ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | Acquired | 1,250,000 | $8.00 |
| 1 Jun 2026 | ORBIMED ADVISORS LLC | director, 10 percent owner: | P-Purchase | Acquired | 625,000 | $8.00 |
| 20 Mar 2026 | Violette Shelia M. | Chief Scientific Officer | A-Award | Acquired | 37,500 | $0.00 |
| 20 Mar 2026 | Morrison Jodie Pope | director, officer: CEO | A-Award | Acquired | 132,000 | $0.00 |
| 20 Mar 2026 | Kalowski Lee | CFO and President | A-Award | Acquired | 53,250 | $0.00 |
| 27 Feb 2026 | Kalowski Lee | CFO and President | S-Sale | Disposed | 3,995 | $4.51 |
| 27 Feb 2026 | Morrison Jodie Pope | director, officer: CEO | S-Sale | Disposed | 9,896 | $4.51 |
| 27 Feb 2026 | Violette Shelia M. | Chief Scientific Officer | S-Sale | Disposed | 2,815 | $4.51 |